United Therapeutics Corp. (NASDAQ: UHTR) has been dealt a win in a lawsuit filed by generic competitors alleging anticompetitive acts — but it isn’t over yet. A judge in the U.S. District Court for New Jersey denied a motion for a preliminary injunction from Sandoz Inc. and RareGen LLC, the companies selling a generic form of Remodulin, a drug that United Therapeutics had under patent until early 2019. The generic drug makers filed a lawsuit last April, saying the Silver Spring biotech had impeded…
from https://www.bizjournals.com/baltimore/news/2020/02/06/court-sides-with-united-therapeutics-in-suit-from.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/190680114532
No comments:
Post a Comment